Mangalam Drugs & Organics Limited (MANGALAM.NS)

INR 80.98

(-1.51%)

Operating Income Summary of Mangalam Drugs & Organics Limited

  • Mangalam Drugs & Organics Limited's latest annual operating income in 2023 was 27.45 Million INR , down -81.65% from previous year.
  • Mangalam Drugs & Organics Limited's latest quarterly operating income in 2024 Q1 was 43.12 Million INR , down -44.93% from previous quarter.
  • Mangalam Drugs & Organics Limited reported an annual operating income of 149.65 Million INR in 2022, down -61.44% from previous year.
  • Mangalam Drugs & Organics Limited reported an annual operating income of 388.05 Million INR in 2021, down -12.2% from previous year.
  • Mangalam Drugs & Organics Limited reported a quarterly operating income of -15.13 Million INR for 2023 Q2, up 77.98% from previous quarter.
  • Mangalam Drugs & Organics Limited reported a quarterly operating income of -68.73 Million INR for 2023 Q1, down -210.37% from previous quarter.

Annual Operating Income Chart of Mangalam Drugs & Organics Limited (2023 - 2007)

Historical Annual Operating Income of Mangalam Drugs & Organics Limited (2023 - 2007)

Year Operating Income Operating Income Growth
2023 27.45 Million INR -81.65%
2022 149.65 Million INR -61.44%
2021 388.05 Million INR -12.2%
2020 441.98 Million INR 184.61%
2019 155.29 Million INR 487.1%
2018 26.45 Million INR -93.43%
2017 402.84 Million INR -9.34%
2016 444.32 Million INR 33.48%
2015 332.87 Million INR 104.31%
2014 162.92 Million INR 179.18%
2013 58.35 Million INR 186.11%
2012 -67.76 Million INR -159.96%
2011 113.02 Million INR 14.59%
2010 98.63 Million INR 20.77%
2009 81.66 Million INR 18.84%
2008 68.72 Million INR 51.32%
2007 45.41 Million INR 0.0%

Peer Operating Income Comparison of Mangalam Drugs & Organics Limited

Name Operating Income Operating Income Difference
Aarey Drugs & Pharmaceuticals Limited 2.83 Million INR -869.964%
Aarti Drugs Limited 7.14 Billion INR 99.616%
Aarti Pharmalabs Limited 3.12 Billion INR 99.122%
Ajanta Pharma Limited 19.67 Billion INR 99.86%
Alembic Limited 767.77 Million INR 96.424%
Alkem Laboratories Limited 19.46 Billion INR 99.859%
Alembic Pharmaceuticals Limited 5.75 Billion INR 99.523%
AstraZeneca Pharma India Limited 4.47 Billion INR 99.386%
Bal Pharma Limited 214.56 Million INR 87.203%
Biofil Chemicals and Pharmaceuticals Limited 20.65 Million INR -32.93%
Bliss GVS Pharma Limited 1.23 Billion INR 97.769%
Brooks Laboratories Limited -72.25 Million INR 138.003%
Bafna Pharmaceuticals Limited 237.66 Million INR 88.447%
Caplin Point Laboratories Limited 7.22 Billion INR 99.62%
Divi's Laboratories Limited 18.31 Billion INR 99.85%
Eris Lifesciences Limited 5.18 Billion INR 99.47%
Granules India Limited 6.52 Billion INR 99.579%
Ind-Swift Limited 1.22 Billion INR 97.76%
Jagsonpal Pharmaceuticals Limited 214.04 Million INR 87.172%
J. B. Chemicals & Pharmaceuticals Limited 7.54 Billion INR 99.636%
Jubilant Pharmova Limited 5.18 Billion INR 99.471%
Kilitch Drugs (India) Limited 208.05 Million INR 86.802%
Medicamen Biotech Limited - INR -Infinity%
Medico Remedies Limited 277.11 Million INR 90.092%
Wockhardt Limited 140 Million INR 80.387%
Orchid Pharma Limited 2.36 Billion INR 98.837%
RPG Life Sciences Limited 2.29 Billion INR 98.802%
Shilpa Medicare Limited 3.76 Billion INR 99.27%
Sigachi Industries Limited 1.47 Billion INR 98.137%
Solara Active Pharma Sciences Limited -3.85 Billion INR 100.713%
Unichem Laboratories Limited - INR -Infinity%
Vaishali Pharma Limited 6.29 Million INR -336.257%
Wanbury Limited 1.7 Billion INR 98.392%
Zydus Lifesciences Limited 45.39 Billion INR 99.94%
FDC Limited 3.03 Billion INR 99.095%
Amrutanjan Health Care Limited 621.02 Million INR 95.579%
Bajaj HealthCare Limited - INR -Infinity%
Dr. Reddy's Laboratories Limited 67.72 Billion INR 99.959%
Glenmark Life Sciences Limited 8.97 Billion INR 99.694%
Ind-Swift Laboratories Limited 2 Billion INR 98.633%
Laurus Labs Limited 3.94 Billion INR 99.305%
Nectar Lifesciences Limited 3.89 Billion INR 99.294%
Par Drugs and Chemicals Limited 551.58 Million INR 95.022%
Hester Biosciences Limited 364.77 Million INR 92.473%
Ipca Laboratories Limited 29.59 Billion INR 99.907%
Venus Remedies Limited 534.65 Million INR 94.864%
ZIM Laboratories Limited 1.09 Billion INR 97.5%
Aurobindo Pharma Limited 104.5 Billion INR 99.974%
Morepen Laboratories Limited 4.17 Billion INR 99.342%
Neuland Laboratories Limited 5.31 Billion INR 99.484%
Sequent Scientific Limited - INR -Infinity%
Suven Pharmaceuticals Limited 4.6 Billion INR 99.404%
Valiant Laboratories Limited - INR -Infinity%
Windlas Biotech Limited 1.29 Billion INR 97.886%
Hikal Limited 1.49 Billion INR 98.162%
Innova Captab Limited 2.53 Billion INR 98.916%
Procter & Gamble Health Limited 2.78 Billion INR 99.014%
Themis Medicare Limited 1.3 Billion INR 97.893%
IOL Chemicals and Pharmaceuticals Limited 4.94 Billion INR 99.444%
Mankind Pharma Limited 40.86 Billion INR 99.933%
Glenmark Pharmaceuticals Limited 6.5 Billion INR 99.578%
Sakar Healthcare Limited 495.5 Million INR 94.459%
Albert David Limited 1.33 Billion INR 97.942%
Lupin Limited 27.75 Billion INR 99.901%
Gufic Biosciences Limited 2.89 Billion INR 99.051%
Sun Pharmaceutical Industries Limited 104.3 Billion INR 99.974%
Lincoln Pharmaceuticals Limited 1.9 Billion INR 98.56%
Syncom Formulations (India) Limited 249.25 Million INR 88.984%
Piramal Enterprises Limited - INR -Infinity%
Torrent Pharmaceuticals Limited 25.33 Billion INR 99.892%
NATCO Pharma Limited 25.96 Billion INR 99.894%
Suven Life Sciences Limited -1.22 Billion INR 102.24%
Krebs Biochemicals & Industries Limited - INR -Infinity%
Strides Pharma Science Limited 5.22 Billion INR 99.475%
Indoco Remedies Limited 1.52 Billion INR 98.199%
Alpa Laboratories Limited 61.51 Million INR 55.364%
Lasa Supergenerics Limited -458 Million INR 105.995%
Sun Pharma Advanced Research Company Limited -4.11 Billion INR 100.667%